Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:17

Vivek Tomar

Written by
Vivek:
- is a Patient Advocate for Lung Cancer, Cancer Research, Clinical Trials and Timely Access to Latest Treatment in India.
- was caregiver & spouse of “Kusum Malik Tomar” a patient of stage 4 Lung Cancer (never-smoker) metastatic to brain, bones & others, who survived 7 long years with Hope, Courage, Research Medicines & Clinical Trials.
- has co-founded India’s 1st Oncogene-Focused Patient support group ‘ALK Positive India’ and also co-founded "Rise To Survive Cancer" an initiative for patient advocacy for Lung Cancer, Cancer Research, Clinical Trials and Timely Access to Latest Treatment in India.
- member of advisory board for cancer research initiative and faculty for cancer awareness programs for Government of India, research centres and many non-profits
- successfully led campaigns to bring many latest cancer medicines in India for patients access, in record time.
- key note speaker and panellist at many national and international conferences and seminars.
- member of IASLC and National Cancer Grid India
- IASLC WCLC 2018 Education Award Winner
- Vivek & Kusum’s story & advocacy work has featured in many national and international media including ‘The Week’, ‘The Hindu’, ‘Zee news’, ‘NDTV’, ‘Big FM’, ‘Josh Talks’, ‘Bloomberg’, ‘Aljazeera’ etc. and also part of a book on inspirational stories called "God is not fair?"
Sunday, 08 August 2021 11:17

Sigourney Bell

Written by
Sunday, 08 August 2021 11:17

Hui Xie

Written by
Sunday, 08 August 2021 11:17

Lillian Leigh

Written by
Following a lung cancer diagnosis in 2014, Australian lawyer Lillian Leigh shifted her focus to advocate for those affected by cancer. Lillian was appointed as an Advisory Council member of Cancer Australia in 2018, where she had also served on its Research and Data Advisory Group for three years. She is a non-executive director of the Thoracic Oncology Group of Australasia, an Executive Committee member of Cancer Voices NSW, a Patient Advisory Board member of Rare Cancers Australia, and a proud member of The ROS1ders. Lillian received the IASLC WCLC Patient Advocacy Award at Vienna in 2016, and has assisted in IASLC's Supportive Training and Advocacy in Research and Science (STARS) Program as a Mentor since 2019.
Sunday, 08 August 2021 11:17

Amy Hauenstein

Written by
Sunday, 08 August 2021 11:17

Rebecca D. Pentz

Written by
Rebecca D. Pentz, PhD
My position as Professor of Research Ethics is unique in that I am embedded in all aspects of translational science conducted at Winship Cancer Institute. This has made possible cutting-edge empirical ethics research into areas of ethical concern, including informed consent and justice issues in clinical trials. The ethics program, which I lead, is currently addressing disparate enrollment in clinical trials in the United States. I was one of two faculty who conducted a week long course in Research Ethics in Uganda, which addressed the issue of well-resourced countries conducting trials in low-resourced countries. During the Uganda course we directly addressed the issue surrounding HIV trials and stigma. We worked with traveling singers who were attempting to destigmatize HIV and encourage screening. Currently, I am the research ethicist for the Winship Lung SPORE and work actively with lung cancer investigators to ensure that the lung cancer clinical trials are ethical.
Sunday, 08 August 2021 11:17

Howard West

Written by
see https://jackwestmd.com/bio-cv/

Dr. West is an Associate Clinical Professor in Medical Oncology, a specialist in thoracic oncology, and serves as Executive Director of Employer Services at City of Hope Comprehensive Cancer Center. He was previously Medical Director of the Thoracic Oncology Program at the Swedish Cancer Institute in Seattle.

Dr. West received an MPhil in Experimental Biology from Cambridge University on a Fulbright Scholarship and a medical degree (magna cum laude) from Harvard Medical School, where Dr. West also conducted research as a Howard Hughes Medical Student Fellow. His postdoctoral training included an internship and residency in internal medicine at the Harvard-affiliated Brigham and Women’s Hospital Boston, MA, followed by a fellowship in medical oncology at the Fred Hutchinson Cancer Research Center/University of Washington in Seattle, WA.

In late, 2002, he moved to Swedish Cancer Institute in Seattle, where he served for over 16 years as Medical Director of the Thoracic Oncology Program, overseeing a broad array of clinical care and research responsibilities. In March, 2019, he moved to the Los Angeles area to dedicate his focus on innovative approaches to delivering sub-specialist expertise across a broader geography, using tools such as remote case reviews and telemedicine consultations.

He has authored dozens of papers and chairs several CME programs and symposia internationally on thoracic oncology, novel educational approaches, and social media in cancer care.

In addition to these activities, he is the Founder & President of Global Resource for Advancing Cancer Education (GRACE); Web Editor for JAMA Oncology; regular correspondent for Medscape; and contributing author and section editor in Lung Cancer for UpToDate.
Sunday, 08 August 2021 11:17

Bhawna Sirohi

Written by
Dr Bhawna Sirohi is a Medical Oncologist at the Apollo Proton Cancer Centre, Chennai, India. She is a global oncologist and is passionate about delivering quality care in LMICs. She started her oncology training in India in 1994 at the Tata Memorial Centre, Mumbai and completed at Royal Marsden NHS Foundation Trust, UK. She has more than two decades of experience as a medical oncologist both in India and UK. She has published more than 120 papers in national and international journals and lectured worldwide.
Sunday, 08 August 2021 11:17

Timothy Hanna

Written by
Dr. Timothy Hanna is a radiation oncologist and clinician scientist at the Ontario Institute for Cancer Research and Queen's University. He is based in the Queen’s University Cancer Research Institute (QCRI) Division of Cancer Care and Epidemiology (CCE), where his research focuses on three translational streams of health services research: quality of care, access to care and health technology assessment.
Sunday, 08 August 2021 11:17

Yasushi Goto

Written by
Dr. Yasushi Goto is currently the Assistant chief, Division of Thoracic Oncology, of National Cancer Center Hospital, Tokyo. He received his medical and doctorate degree in University of Tokyo. His current main researches are medical oncology (thoracic malignancies) and translational medicine. He has engaged in more than 50 scientific papers including JTO, JCO, Lancet and NEJM. He is a member of steering committee in several global and domestic studies, and the primary investigators of JCOG trial which is evaluating the efficacy of discontinuing PD-L1 axis inhibitors, and others.
He is also a staff in Section of Knowledge Integration of Center for Cancer Genomics and Advanced Therapeutics and Rare Cancer Center, director of patient supportive organizations, secretary general of JSMO (Japanese Society of Medical Oncology), panel member of guideline and database committee in Japanese Lung Cancer Society, associate editor of Japanese Journal of Clinical Oncology and communication committee member of IASLC.
Page 351 of 371